MedSci在“2011干细胞技术临床转化应用讲座与培训”上精彩讲座

2011-06-07 MedSci MedSci原创

        2011年6月4日-5日,为期两天的“2011干细胞技术临床转化应用讲座与培训”在上海同济大学成功举办。来自全国各地约200位业内人士聆听了17位干细胞技术专家和临床转化应用知名学者的精彩报告。此次讲座加强行业交流,分享了干细胞技术进展,为干细胞基础及临床研究领域的高科技人才培养提供有效的支持和交流平台。 &n

2011年6月4日-5日,为期两天的“2011干细胞技术临床转化应用讲座与培训”在上海同济大学成功举办。来自全国各地约200位业内人士聆听了17位干细胞技术专家和临床转化应用知名学者的精彩报告。此次讲座加强行业交流,分享了干细胞技术进展,为干细胞基础及临床研究领域的高科技人才培养提供有效的支持和交流平台。

如何将干细胞技术临床转化应用的全新成果,最迅速有效的展示给更多人来分享,一直困扰着广大科研人员和临床工作者,撰写优秀的学术文章并在高水平的杂志发表是当前时代的发展需求。MedSci为大家提供了一种全新且行之有效的方法体系。

资料下载干细胞研究在临床科研上的应用,结合SCI论文写作和课题申请

相关链接:

2011干细胞技术临床转化应用讲座与培训官网

2011干细胞技术临床转化应用讲座与培训在同济大学获圆满成功

干细胞科研领域的牛人们

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=37336, encodeId=77693e33668, content=Thanks for your thtuohgs. It's helped me a lot., beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=kevin, createdTime=Sun Sep 27 06:56:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739789, encodeId=09be1e3978938, content=<a href='/topic/show?id=c8a22306335' target=_blank style='color:#2F92EE;'>#临床转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23063, encryptionId=c8a22306335, topicName=临床转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=853b34558513, createdName=ms9833124466084992, createdTime=Tue Aug 02 21:11:00 CST 2011, time=2011-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079660, encodeId=1afe20e966081, content=<a href='/topic/show?id=a87448e7286' target=_blank style='color:#2F92EE;'>#干细胞技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48772, encryptionId=a87448e7286, topicName=干细胞技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Mon May 07 06:11:00 CST 2012, time=2012-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605594, encodeId=49081605594ff, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Jun 09 05:11:00 CST 2011, time=2011-06-09, status=1, ipAttribution=)]
    2015-09-27 kevin

    Thanks for your thtuohgs. It's helped me a lot.

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=37336, encodeId=77693e33668, content=Thanks for your thtuohgs. It's helped me a lot., beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=kevin, createdTime=Sun Sep 27 06:56:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739789, encodeId=09be1e3978938, content=<a href='/topic/show?id=c8a22306335' target=_blank style='color:#2F92EE;'>#临床转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23063, encryptionId=c8a22306335, topicName=临床转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=853b34558513, createdName=ms9833124466084992, createdTime=Tue Aug 02 21:11:00 CST 2011, time=2011-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079660, encodeId=1afe20e966081, content=<a href='/topic/show?id=a87448e7286' target=_blank style='color:#2F92EE;'>#干细胞技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48772, encryptionId=a87448e7286, topicName=干细胞技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Mon May 07 06:11:00 CST 2012, time=2012-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605594, encodeId=49081605594ff, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Jun 09 05:11:00 CST 2011, time=2011-06-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=37336, encodeId=77693e33668, content=Thanks for your thtuohgs. It's helped me a lot., beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=kevin, createdTime=Sun Sep 27 06:56:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739789, encodeId=09be1e3978938, content=<a href='/topic/show?id=c8a22306335' target=_blank style='color:#2F92EE;'>#临床转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23063, encryptionId=c8a22306335, topicName=临床转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=853b34558513, createdName=ms9833124466084992, createdTime=Tue Aug 02 21:11:00 CST 2011, time=2011-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079660, encodeId=1afe20e966081, content=<a href='/topic/show?id=a87448e7286' target=_blank style='color:#2F92EE;'>#干细胞技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48772, encryptionId=a87448e7286, topicName=干细胞技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Mon May 07 06:11:00 CST 2012, time=2012-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605594, encodeId=49081605594ff, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Jun 09 05:11:00 CST 2011, time=2011-06-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=37336, encodeId=77693e33668, content=Thanks for your thtuohgs. It's helped me a lot., beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=kevin, createdTime=Sun Sep 27 06:56:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1739789, encodeId=09be1e3978938, content=<a href='/topic/show?id=c8a22306335' target=_blank style='color:#2F92EE;'>#临床转化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23063, encryptionId=c8a22306335, topicName=临床转化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=853b34558513, createdName=ms9833124466084992, createdTime=Tue Aug 02 21:11:00 CST 2011, time=2011-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2079660, encodeId=1afe20e966081, content=<a href='/topic/show?id=a87448e7286' target=_blank style='color:#2F92EE;'>#干细胞技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48772, encryptionId=a87448e7286, topicName=干细胞技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=jiangjun073, createdTime=Mon May 07 06:11:00 CST 2012, time=2012-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605594, encodeId=49081605594ff, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Thu Jun 09 05:11:00 CST 2011, time=2011-06-09, status=1, ipAttribution=)]
    2011-06-09 智智灵药

相关资讯

预告:MedSci“临床科研中国行”全国巡回讲座(杭州站)

        MedSci是综合临床医学和科研学术服务平台,致力于从事医学临床和科研的教育、 培训和医学学术服务指导,全面提升中国医学和科研学术水平,全面对接中国和国际最 新研究成果。现MedSci正开展“临床科研中国行”全国巡回讲座,足迹已布上海、天津 、北京、成都、重庆、山东等地。   &nbs

MedSci参加第三届中英癌症生物学前沿研讨会

        2011年5月19日,第三届中英癌症生物学前沿研讨会暨MRC-中国上海研讨会——“细胞死亡、干细胞与癌症”国际系列研讨会在上海隆重拉开帷幕,350多位业内人士汇聚一堂,聆听国内外干细胞领域顶级科研和临床研究专家的最新研究成果报道。       &nbs

MedSci科室讲座——上海第十人民医院骨科

       2011年5月27日,MedSci应上海第十人民医院骨科邀请,做了题为《Sci文章常见问题解析》的SCI专业知识交流会,从审稿编辑角度看SCI论文、SCI论文的审稿过程及期刊回函分析、选择杂志要考虑的因素和选择投稿杂志的技巧等多个方面与科室医生进行交流与探讨。      &

MedSci 2011 端午节放假通知

尊敬的MedSci客户和会员: 根据《国务院办公厅关于2011年部分节假日安排的通知》,为便于大家及早安排节假日事宜,MedSci 2011年端午节放假安排如下: 6月4日至6日放假公休,共3天,6月7日(周二)正常上班。 在放假期间,MedSci将不再安排相关客户服务支持等事宜,但仍然正常接收邮件,请发送邮件至 editing@medsci.cn,我们将在上班后尽快为您处理,敬请大家理解

MedSci的“专业英语修改服务”更名为“专业审查润色”

    随着MedSci发展,服务越来越深入,因此,对不少服务进行更为深度的划分,同时不断提高编辑的质量。从过去简单的语言修改服务(母语化润色服务),到对文章结构进行审查(专业审查润色),以及到现在对论文表述欠严谨,逻辑性欠妥,以及文章的创新性的提炼方面(专业改写服务),以及从课题设计开始进行审查(课题设计服务)。完全突破了同行公司仅能做简单的语言润色,帮助用户在临床

MedSci祝会员端午节快乐!

MedSci祝会员端午节快乐!